THE ANTI-CD20 ANTIBODY RITUXIMAB REDUCES THE INFLAMMATORY AND PROTHROMBOTIC PROFILE OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS AND MODULATES THE ACTIVITY OF ENDOTHELIAL CELLS

Simple item page
dc.conference.dateJUN 14-17, 2017
dc.conference.titleAnnual European Congress of Rheumatology
dc.contributor.authorCecchi, I.
dc.contributor.authorPerez-Sanchez, C.
dc.contributor.authorRuiz-Limon, P.
dc.contributor.authorde la Rosa, I. Arias
dc.contributor.authorAbalos-Aguilera, M. C.
dc.contributor.authorJimenez-Gomez, Y.
dc.contributor.authorOrtega, R.
dc.contributor.authorCollantes-Estevez, E.
dc.contributor.authorEscudero, A.
dc.contributor.authorBarbarroja, N.
dc.contributor.authorSciascia, S.
dc.contributor.authorLopez-Pedrera, C.
dc.contributor.authoraffiliation[Cecchi, I.] Coordinating Ctr Piemonte & Valle dAosta Network, Ctr Res Immunopathol & Rare Dis, Dept Clin & Biol Sci, Turin, Italy
dc.contributor.authoraffiliation[Sciascia, S.] Coordinating Ctr Piemonte & Valle dAosta Network, Ctr Res Immunopathol & Rare Dis, Dept Clin & Biol Sci, Turin, Italy
dc.contributor.authoraffiliation[Perez-Sanchez, C.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Ruiz-Limon, P.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[de la Rosa, I. Arias] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Jimenez-Gomez, Y.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega, R.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes-Estevez, E.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero, A.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Barbarroja, N.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Pedrera, C.] Univ Cordoba, Reina Sofia Hosp, IMIBIC, GC Rheumatol 5, Cordoba, Spain
dc.contributor.funderISCIII
dc.date.accessioned2025-01-07T13:28:20Z
dc.date.available2025-01-07T13:28:20Z
dc.date.issued2017-06-01
dc.identifier.doi10.1136/annrheumdis-2017-eular.4916
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/76/Suppl_2/497.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25555
dc.identifier.wosID413181401448
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.number497-497
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleTHE ANTI-CD20 ANTIBODY RITUXIMAB REDUCES THE INFLAMMATORY AND PROTHROMBOTIC PROFILE OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS AND MODULATES THE ACTIVITY OF ENDOTHELIAL CELLS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number76
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía